CD8A and breast carcinoma: Unloaded MHAs did not compromise the viability of 4T1 breast cancer cells, Panc02 pancreatic cancer cells, LLC lung cancer cells, H22 hepatic cancer cells, M0-BMDMs, naive CD8+ T cells, or activated CD8+ T cells.